Posted by Leighwit on February 16, 2000, at 15:15:11
In reply to Re: FDA-Rebox. doesn't look too promising, posted by PattyG on February 16, 2000, at 7:51:15
I'm in the US and taking reboxetine through my Pdoc who orders it from a pharmacy in London. I consulted with a psychopharmacologist also before starting this drug.
Drugs (at least those from the UK) without FDA involvement, have minimal labeling. You would not believe how vague the package insert is. Someone in the UK on reboxetine commented on another ng about how sophomoric the labeling information is on all of their drugs. "Pathetic" was the term I believe he used.
I'm not defending the slow approval process by any means. But I do have a new appreciation for the information the FDA requires the pharmaceutical companies to provide to the public.
I have juvenile-onset (Type I) insulin-dependent diabetes. The contraindications for ADs matter a great deal to all of us; particularly those with chronic medical conditions.
If I lived in the UK, I'd be researching FDA information to make safe choices.
Just some thoughts about the flip side of the coin.
LW
poster:Leighwit
thread:21540
URL: http://www.dr-bob.org/babble/20000209/msgs/21829.html